Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes.

Hydes, T J; Summers, N; Brown, E; Alam, U; Thomaides-Brears, H; Wilding, J P H; Cuthbertson, D J

Hydes, T J; Summers, N; Brown, E; Alam, U; Thomaides-Brears, H; Wilding, J P H; Cuthbertson, D J.

Affiliation

Hydes TJ; Department of Gastroenterology and Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Summers N; Liverpool University Hospitals NHS Foundation Trust, University Hospital Aintree, Liverpool, UK.
Brown E; Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK.
Alam U; Metabolism and Nutrition Research Group, Clinical Sciences Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Thomaides-Brears H; Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK.
Wilding JPH; Metabolism and Nutrition Research Group, Clinical Sciences Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Cuthbertson DJ; Division of Diabetes, Endocrinology and Gastroenterology, Institute of Human Development, University of Manchester, Manchester, UK.

Diabet Med ; 37(11): 1793-1806, 2020 11.

Article in En | MEDLINE | ID: mdl-32619031

Subject(s)

Diabetes Mellitus, Type 2/metabolism; Non-alcoholic Fatty Liver Disease/diagnosis; Obesity/metabolism; Alanine Transaminase/metabolism; Aspartate Aminotransferases/metabolism; Bariatric Surgery; Biopsy; Diabetes Mellitus, Type 2/epidemiology; Diabetes Mellitus, Type 2/therapy; Diet Therapy; Elasticity Imaging Techniques; Exercise; Glucagon-Like Peptide-1 Receptor/agonists; Humans; Hypoglycemic Agents/therapeutic use; Liver/pathology; Magnetic Resonance Imaging; Mass Screening; Metabolic Syndrome/epidemiology; Metabolic Syndrome/metabolism; Non-alcoholic Fatty Liver Disease/epidemiology; Non-alcoholic Fatty Liver Disease/metabolism; Non-alcoholic Fatty Liver Disease/therapy; Obesity/epidemiology; Obesity/therapy; Platelet Count; Risk Factors; Severity of Illness Index; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Thiazolidinediones/therapeutic use; gamma-Glutamyltransferase/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Non-alcoholic Fatty Liver Disease / Obesity Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2020 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google